1.4(top 50%)
impact factor
1.3K(top 20%)
papers
11.0K(top 20%)
citations
44(top 20%)
h-index
1.6(top 50%)
extended IF
1.6K
all documents
11.8K
doc citations
67(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen speciesFuture Cardiology2012238
2From particles to patients: oxidative stress and the cardiovascular effects of air pollutionFuture Cardiology2012212
3Type-2 diabetes mellitus and cardiovascular diseaseFuture Cardiology2018197
4PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γFuture Cardiology2017183
5Kounis syndrome: a new twist on an old diseaseFuture Cardiology2011168
6Rho kinase as a therapeutic target in cardiovascular diseaseFuture Cardiology2011155
7Astaxanthin, oxidative stress, inflammation and cardiovascular diseaseFuture Cardiology2009145
8Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular diseaseFuture Cardiology2010122
9Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillationFuture Cardiology2015121
10PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-αFuture Cardiology2017120
11Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisitedFuture Cardiology2012116
12Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementFuture Cardiology2012116
13The golden age of minimally invasive cardiothoracic surgery: current and future perspectivesFuture Cardiology2011112
14Targeting cardiovascular disease with novel SIRT1 pathwaysFuture Cardiology2012102
15Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemiaFuture Cardiology200585
16Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapiesFuture Cardiology201378
17Atrial fibrillation and ethnicity: the known, the unknown and the paradoxFuture Cardiology200971
18Inclisiran for the treatment of cardiovascular disease: the ORION clinical development programFuture Cardiology201870
19Stem cells in cardiac repairFuture Cardiology201167
20Role of NADPH oxidase in atherosclerosisFuture Cardiology200964
21A life course approach to cardiovascular agingFuture Cardiology201564
22Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trialFuture Cardiology201764
23The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign?Future Cardiology201062
24Using ST2 in cardiovascular patients: a reviewFuture Cardiology201459
25ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeksFuture Cardiology201557
26The future of warfarin pharmacogenetics in under-represented minority groupsFuture Cardiology201256
27COVID-19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burdenFuture Cardiology202055
28PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016Future Cardiology201254
29Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical courseFuture Cardiology201254
30Mesenchymal stromal cells for cardiovascular repair: current status and future challengesFuture Cardiology200953
31Pulmonary hypertension in congenital heart diseaseFuture Cardiology201853
32Novel imaging techniques for diffuse myocardial fibrosisFuture Cardiology201152
33Bacterial invasion of vascular cell types: vascular infectology and atherogenesisFuture Cardiology201252
34Cardiovascular dysfunctions and sympathovagal imbalance in hypertension and prehypertension: physiological perspectivesFuture Cardiology201352
35Mechanisms of myocardial ischemia–reperfusion injury and the cytoprotective role of minocycline: scope and limitationsFuture Cardiology201552
36Elinogrel: pharmacological principles, preclinical and early phase clinical testingFuture Cardiology201051
37Should torsemide be the loop diuretic of choice in systolic heart failure?Future Cardiology201251
38Estrogen, aging and the cardiovascular systemFuture Cardiology200949
39The epicardium as a candidate for heart regenerationFuture Cardiology201249
40Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectivesFuture Cardiology200948
41The obesity paradox and outcome in heart failure: is excess bodyweight truly protective?Future Cardiology201048
42Reviewing peripartum cardiomyopathy: current state of knowledgeFuture Cardiology200947
43New directions in antiarrhythmic drug therapy for atrial fibrillationFuture Cardiology201347
44Depression and anxiety in patients with chronic heart failureFuture Cardiology201847
45Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all?Future Cardiology201246
46Air embolism: diagnosis and managementFuture Cardiology201745
47Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitorsFuture Cardiology201143
48Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic frameworkFuture Cardiology201143
49Effects of caffeine and coffee consumption on cardiovascular disease and risk factorsFuture Cardiology200740
50Sudden cardiac death in COVID-19 patients, a report of three casesFuture Cardiology202140